aminopentamide (Compound)

Synonyms:Aminopentamide, Dimevamide, 60-46-8, 4-(dimethylamino)-2,2-diphenylpentanamide, Centrine, Dimevamide [INN], AMINOPENTAMIDE SULFATE (200 MG), Dimevamide, (+)-, Dimevamide, (-)-, Centrine, (+)-, Centrine, (-)-, Aminopentamide, (+)-, Aminopentamide, (-)-, HI3DVH9WMI, Valeramide-om, (+)-, Valeramide-om, (-)-, BL-139, 4-Dimethylamino-2,2-diphenylvaleramide, 661TMO8UM4, IP1B47L61M, NSC-759162, Dimevamide sulfate, Valeramide-OM, Valeramide, 4-(dimethylamino)-2,2-diphenyl-, BL-139, (+)-, BL-139, (-)-, Aminopentamide sulphate, Valeramide, 4-(dimethylamino)-2,2-diphenyl-, (+)-, Valeramide, 4-(dimethylamino)-2,2-diphenyl-, (-)-, Dimevamida, Dimevamidum, BL 139; Centrine; Dimevamide; Valeramide-OM; dl-Aminopentamide, aminopentamide hydrogen sulfate, dl-Aminopentamide, Aminopentamide acid sulfate, dl-, 5985-88-6, 6078-64-4, Dimevamidum [INN-Latin], Dimevamida [INN-Spanish], UNII-IP1B47L61M, Dimevamid, EINECS 200-479-8, (+)-Aminopentamide, (?)-Aminopentamide, BL 139, UNII-HI3DVH9WMI, AMINOPENTAMIDE [MI], DIMEVAMIDE [MART.], DIMEVAMIDE [WHO-DD], UNII-661TMO8UM4, alpha,alpha-Diphenyl-gamma-dimethylaminovaleramide, CHEMBL92915, SCHEMBL251458, Aminopentamide sulfate(200 mg), DTXSID2057605, CHEBI:91829, BCP32413, Benzeneacetamide, alpha-(2-(dimethylamino)propyl)-alpha-phenyl-, MFCD00865194, DB15597, NSC 759162, SBI-0206820.P001, F20770, AB01563100_01, BRD-A69917777-065-01-4, Q27163625, alpha,alpha-Diphenyl-gamma-dimethylaminovaleramide, (-)-, alpha-(2-(Dimethylamino)propyl)-alpha-phenylbenzeneacetamide, Dimevamida;4-Dimethylamino-2,2-diphenylva-leramide;BL-139, alpha-(2-(Dimethylamino)propyl)-alpha-phenylbenzeneacetamide sulfate, .ALPHA.,.ALPHA.-DIPHENYL-.GAMMA.-DIMETHYLAMINOVALERAMIDE, (-)-, .ALPHA.-(2-(DIMETHYLAMINO)PROPYL)-.ALPHA.-PHENYLBENZENEACETAMIDE, BENZENEACETAMIDE, .ALPHA.-(2-(DIMETHYLAMINO)PROPYL)-.ALPHA.-PHENYL-, Benzeneacetamide, alpha-(2-(dimethylamino)propyl)-alpha-phenyl-, (+)-, BENZENEACETAMIDE, .ALPHA.-(2-(DIMETHYLAMINO)PROPYL)-.ALPHA.-PHENYL-, (+)-

Pubchem:PUBCHEM:22565

Id:7f805276-32c5-536e-989c-8976d81d293e

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View aminopentamide's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for aminopentamide.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with aminopentamide.

Results found

Linked to

	Label	Description
	BRD-A69917777-065-02-2 Substance (Entity type)	A Substance
	aminopentamide (5199b222-30e0-4fc5-932f-6f0d0e5b7910) Collection (Entity type)	Metadatata for aminopentamide
	DCSTRUCT ID 00170 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00170; PubChem_CID:22565, FILE=drugcentral_drug_00170.json)
	aminopentamide in similarity relationship with 7,8,3',4'-tetrahydroxyflavone Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	aminopentamide negatively regulates LCN2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	aminopentamide positively regulates FKBP1B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	aminopentamide negatively regulates SLC12A2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	aminopentamide positively regulates FABP5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	aminopentamide negatively regulates CEACAM6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	aminopentamide negatively regulates S100P Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS